|
OMIM |
Link |
Information gain |
01 |
|
hla-d histocompatibility type
|
[NCBI]
|
0.00186636
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000841397
|
|
|
TNFSF6
|
[NCBI]
|
0.000727543
|
|
|
JMML
|
[NCBI]
|
0.000513912
|
|
|
FA
|
[NCBI]
|
0.000487233
|
|
|
TNF
|
[NCBI]
|
0.00044534
|
|
|
WAS
|
[NCBI]
|
0.000392092
|
|
|
omenn syndrome
|
[NCBI]
|
0.000371194
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000205928
|
|
|
FGF7
|
[NCBI]
|
0.000186792
|
|
|
CHS
|
[NCBI]
|
0.000172591
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
0.000131464
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000106363
|
|
|
HLA-DRB1
|
[NCBI]
|
0.000105144
|
|
|
SLE
|
[NCBI]
|
0.000104306
|
|
|
RA
|
[NCBI]
|
0.000101943
|
|
|
SCIDX1
|
[NCBI]
|
8.49983e-05
|
|
|
ALD
|
[NCBI]
|
7.89989e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
7.2073e-05
|
|
|
UGT2B17
|
[NCBI]
|
6.57063e-05
|
|
|
minor histocompatibility antigen hb-1
|
[NCBI]
|
6.57063e-05
|
|
|
S100A6
|
[NCBI]
|
6.57063e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
6.51069e-05
|
|
|
SDS
|
[NCBI]
|
6.47415e-05
|
|
|
achondroplasia, so-called, and severe combined immunodeficiency
|
[NCBI]
|
6.29518e-05
|
|
|
HLA-A
|
[NCBI]
|
5.87926e-05
|
|
|
IL18
|
[NCBI]
|
5.81316e-05
|
|
|
DBA
|
[NCBI]
|
5.57278e-05
|
|
|
JAK3
|
[NCBI]
|
5.35369e-05
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
5.19389e-05
|
|
|
MG
|
[NCBI]
|
4.9334e-05
|
|
|
CTSH
|
[NCBI]
|
4.67508e-05
|
|
|
SCGF
|
[NCBI]
|
4.67508e-05
|
|
|
PECAM1
|
[NCBI]
|
4.67508e-05
|
|
|
LPG
|
[NCBI]
|
4.62094e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
4.62094e-05
|
|
|
IL10
|
[NCBI]
|
4.35171e-05
|
|
|
SAA2
|
[NCBI]
|
4.33864e-05
|
|
|
BCL2A1
|
[NCBI]
|
3.88998e-05
|
|
|
TNFSF4
|
[NCBI]
|
3.88998e-05
|
|
|
ICOSLG
|
[NCBI]
|
3.88998e-05
|
|
|
ANXA2
|
[NCBI]
|
3.72486e-05
|
|
|
INPP5D
|
[NCBI]
|
3.5837e-05
|
|
|
CBP2
|
[NCBI]
|
3.5837e-05
|
|
|
LIP
|
[NCBI]
|
3.39235e-05
|
|
|
STAT4
|
[NCBI]
|
2.93718e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.81723e-05
|
|
|
hurler syndrome
|
[NCBI]
|
2.66042e-05
|
|
|
VEGF
|
[NCBI]
|
2.64969e-05
|
|
|
DST
|
[NCBI]
|
2.64926e-05
|
|
|
SOCS1
|
[NCBI]
|
2.51099e-05
|
|
|
CCL21
|
[NCBI]
|
2.4691e-05
|
|
|
IFNG
|
[NCBI]
|
2.4691e-05
|
|
|
CGD
|
[NCBI]
|
2.31861e-05
|
|
|
CTSC
|
[NCBI]
|
2.21924e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.0232e-05
|
|
|
LCN2
|
[NCBI]
|
1.78219e-05
|
|
|
HGF
|
[NCBI]
|
1.50671e-05
|
|
|
SRY
|
[NCBI]
|
1.49249e-05
|
|
|
GUSB
|
[NCBI]
|
1.20867e-05
|
|
|
EPO
|
[NCBI]
|
1.1255e-05
|
|
|
ADA
|
[NCBI]
|
1.12065e-05
|
|
|
ALK
|
[NCBI]
|
5.32953e-06
|
|
|
CVID
|
[NCBI]
|
5.05059e-06
|
|
|
TNFSF10
|
[NCBI]
|
5.00626e-06
|
|
|
PRL
|
[NCBI]
|
4.55016e-06
|
|
|
IL2
|
[NCBI]
|
3.22435e-06
|
|
|
EGF
|
[NCBI]
|
3.11029e-06
|
|
|
AHR
|
[NCBI]
|
3.0047e-06
|
|
|
POMC
|
[NCBI]
|
2.62091e-06
|
|
|
GAPDH
|
[NCBI]
|
2.55271e-06
|
|
|
PF4
|
[NCBI]
|
2.18812e-06
|
|
|
ALB
|
[NCBI]
|
1.87942e-06
|
|
|
VIP
|
[NCBI]
|
1.71471e-06
|
|
|
CAT
|
[NCBI]
|
5.95309e-07
|
|
|
PPARA
|
[NCBI]
|
3.60508e-07
|
|
|
SPP1
|
[NCBI]
|
1.62143e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
1.56687e-07
|
|
|
TYMS
|
[NCBI]
|
5.39163e-08
|
|
|
VDR
|
[NCBI]
|
1.8976e-08
|
|